N-methyl-D-aspartate (NMDA) receptors constitute a major subtype of glutamate receptors at extrasynaptic sites that link multiple intracellular catabolic processes responsible for irreversible neuronal death. Here, we report that cerebral ischemia recruits death-associated protein kinase 1 (DAPK1) into the NMDA receptor NR2B protein complex in the cortex of adult mice. DAPK1 directly binds with the NMDA receptor NR2B C-terminal tail consisting of amino acid 1292-1304 (NR2B CT ). A constitutively active DAPK1 phosphorylates NR2B subunit at Ser-1303 and in turn enhances the NR1/NR2B receptor channel conductance. Genetic deletion of DAPK1 or administration of NR2B CT that uncouples an activated DAPK1 from an NMDA receptor NR2B subunit in vivo in mice blocks injurious Ca 2+ influx through NMDA receptor channels at extrasynaptic sites and protects neurons against cerebral ischemic insults. Thus, DAPK1 physically and functionally interacts with the NMDA receptor NR2B subunit at extrasynaptic sites and this interaction acts as a central mediator for stroke damage.
INTRODUCTION
Glutamate is the major excitatory transmitter in the mammalian central nervous system (CNS) and plays an essential role in neural development, excitatory synaptic transmission, and plasticity (Greengard, 2001) . Immediately following ischemia, however, glutamate accumulates at synapses (Drejer et al., 1985; Rossi et al., 2000) , resulting in extensive stimulation of its receptors that can eventually be toxic to neurons (Lipton, 2006; Lo et al., 2003) . Glutamate activates three classes of ionophore-linked postsynaptic receptors, namely N-methyl-Daspartate (NMDA) and a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) and kainate receptors. NMDA receptor toxicity is dependent on extracellular Ca 2+ , and reflects a large amount of Ca 2+ influx directly through the receptor-gated ion channels (Simon et al., 1984 ; for review, see Lipton, 2006; Lo et al., 2003) . As most AMPA receptor channels have poor Ca 2+ permeability, injury may result primarily from indirect Ca 2+ entry through voltage-gated Ca 2+ channels, Ca 2+ -permeable acidsensing ion channels (Xiong et al., 2004) , and possibly via a cleavage of Na + /Ca 2+ exchangers (Bano et al., 2005) . Ca 2+ overload triggers several downstream lethal reactions including nitrosative stress (Aarts et al., 2003; Uehara et al., 2006) , oxidative stress (Kinouchi et al., 1991) and mitochondrial dysfunction Fiskum et al., 1999) . Thus, over-stimulation of glutamate receptors can be considered as a primary intracellular event that induces neuronal death in stroke. NMDA receptors constitute the major subtype of glutamate receptors, and normally participate in rapid excitatory synaptic transmission. To date, a variety of NMDA receptor subunit proteins (NR1, NR2A-D) have been cloned (Madden, 2002) . Native NMDA receptors appear to be heteroligomeric complexes consisting of an essential NR1 subunit and one or more regulatory NR2 subunits (NR2A-D) and possibly the more recently identified NR3 subunit (Chatterton et al., 2002) . Since the NR2C-(and possibly NR2D-) containing receptors have very low probability for their channel opening (Sprengel et al., 1998) , both NR2A-and NR2B-containing NMDA receptors are considered as the main types of functional NMDA receptor channels in CNS neurons (Madden, 2002) . Activation of NMDA receptors requires two coincident events: 1) binding to the coagonists of glutamate and glycine, and 2) simultaneous membrane depolarization, which removes the Mg 2+ blockade of the channel pore, leading to the influx of Ca 2+ . Under physiological conditions, the entrance of Ca 2+ produces partial inhibition of NMDA receptors via Ca 2+ -dependent inactivation, thereby preventing the intracellular Ca 2+ overload (Krupp et al., 1999) . Under pathological conditions, however, this negative feedback in Ca 2+ regulation of NMDA receptors is disabled, resulting in excessive Ca 2+ influx through the receptor channels (Wang et al., 2003a) . Ca 2+ overload triggers multiple intracellular catabolic processes, and thus induces an irreversible death of neuronal cells in the brain (for review, see Lipton, 2006; Lo et al., 2003) .
Although over stimulation of NMDA receptors contributes to ischemic neuronal death, blocking them totally could be deleterious to animals and humans because targeting these receptors also blocks the physiological actions of the receptor as well. In the present study, we report that DAPK1, or death-associated protein kinase 1, acts as a specific ''cell death signal'' that couples NMDA receptor channels at extrasynaptic sites to ischemic neuronal death. We also demonstrate that uncoupling of an activated DAPK1 from the NMDA receptor complex protects against brain damage in stroke without affecting the physiological actions of the NMDA receptors. Thus, targeting DAPK1-NMDA receptor interaction can be considered as a practical strategy for stroke therapy.
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RESULTS
Cerebral Ischemia Recruits DAPK1 into NMDA Receptor NR2B Protein Complex To explore the cell death signals that are linked with NMDA receptors in stroke damage, we used anti-NMDA receptor NR2B antibodies to precipitate the NMDA receptor complex in the membrane extracts from the cortex of mice that had been subjected to focal cerebral ischemia or sham operation (for details, see Experimental Procedures). The precipitates from both groups were separated on the SDS-PAGE and stained with Coomassie blue (Figures 1A and 1B) . Compared to the control group, the additional protein bands on the gel with estimated size of 66 kDa and 150 kDa were observed in the ischemic group. We then analyzed the protein components in these bands using a reverse phase Nano-Liquid Chromatography-Tandem Mass Spectrometry (NLC/MS) approach. Five peptide sequences: AEQHEHVAGLLAR, DKSGETALAVAAR, GLFFQQLRPTQNLQPR, HYLSPQQLR, and RGVSREDIER, were found to match deathassociated protein kinase 1 (DAPK1, see Tables S1 and S2) . We next probed the precipitates with antibody against DAPK1 and confirmed the existence of endogenous DAPK1 in the NMDA receptor complex ( Figure 1C , see also Figure S1 ). We also carried out the reciprocal coimmuno-precipitation, in which anti-DAPK1 was used to precipitate NMDA receptor NR1, NR2B subunits, and their functional interacting partner PSD-95, and CaMK-II ( Figure 1D ). Single neuronal labeling demonstrated a colocalization of DAPK1 with NMDA receptor NR2B subunits at the post-synaptic spines ( Figures 1E-1G ). Thus, DAPK1 is physically associated with NMDA receptors.
To identify a direct binding region of NMDA receptor NR2B subunit with DAPK1, we generated a series of NMDA receptor NR2B C-terminal deletion mutants fused with glutathione-S-transferase (GST, Figure 2A ). We found that only the NR2B 1292-1304 fragment was capable of binding with DAPK1 ( Figure 2B Figure 2C ), but it did not affect the association of PSD-95 or CaMK-II with the NMDA receptor NR2B subunit ( Figure 2D ).
DAPK1 Activation Enhances the NR1/NR2B Channel Conductance
Having determined a binding domain of DAPK1 with the NMDA receptor NR2B subunit, we then examined whether DAPK1 functionally regulates NMDA receptor channel activity. We coexpressed the NR1/NR2B receptors with a constitutively active DAPK1 (cDAPK1), or the wild-type DAPK1 (wDAPK1) in HEK293 cells. We found that cDAPK1 increased the peak amplitude of the recombinant NR1/NR2B receptor currents (Figure 3A) , but not the NR1/NR2A receptor currents ( Figure 3B ), at a range of holding potentials from À100 to +100 mV. Since the decay time constants and the reversal potentials were not changed ( Figure 3A ), cDAPK1 specifically increases the recombinant NR1/NR2B receptor channel conductance. To determine whether enhancement of NR1/NR2B receptor currents is mediated directly by DAPK1-NR2B interaction, we made use of NR2B subunit C-terminal peptide, NR2B CT , at a concentration of 10, 25, or 50 mM, which was diffused directly into the recording cells via path electrode ( Figure 3C ). After a 10 min diffusion of 50 mM NR2B CT , the peak amplitude of the whole-cell currents decreased by 0.56 ± 0.086 of the baseline (mean ± standard error of the mean [SEM], Figure 3C ). A peptide with the same amino acid composition but in random order scrambled NR2B CT (sNR2B CT ) served as control, and did not reduce the recombinant NR1/NR2B receptor currents (0.98 ± 0.11 of the baseline, mean ± SEM). Whole-cell currents in HEK293 cells coexpressing NR1/NR2B with wDAPK1 were not affected by 50 mM NR2B CT ( Figure 3D ). Thus, enhancement of the recombinant NR1/NR2B receptor channel conductance is mediated by activated DAPK1 binding with NR2B subunit.
DAPK1 Activation Phosphorylates NR2B Subunit at Ser-1303
We next examined whether an activated DAPK1 phosphorylates NR2B subunit at Ser-1303, ( Figure 3E ), a residue corresponding to a phosphorylation site (KXXRXXSX) of DAPK1 (Schumacher and Schavocky, 2004 Figure 3E ). To determine whether phosphorylation of NR2B at Ser-1303 is sufficient to modulate the NR1/ NR2B receptor channel activity, whole-cell currents were recorded from HEK293 cells coexpressing the NR1/NR2B or the mutant NR1/NR2BS 1303 A with wDAPK1 ( Figure 3F ) or cDAPK1 ( Figure 3G ). We found that cDAPK1 increased the peak amplitude of the recombinant NR1/NR2B receptor currents, but not the mutant NR1/NR2BS 1303 A receptor currents, at a range of holding potentials from À80 to +80 mV ( Figure 3G ). Thus, an activated DAPK1 enhances NR1/NR2B receptor channel conductance by phosphorylating NR2B subunit at Ser-1303.
Generation of Null Mutant Mice Lacking the DAPK1 Gene
To determine whether an activated DAPK1 physically and functionally interacts with synaptic NMDA receptor NR2B subunit in vivo, we generated null mutant mice with deficiency in expression of DAPK1 (DAPK1 À/À mice). b-gal, a marker for DAPK1 deletion, was observed throughout the brain of the DAPK1 À/À mice, including the cortex and hippocampus (Figure 4A ). RT-PCR and western blot analysis revealed undetectable levels of DAPK1 mRNA ( Figure 4B ) and proteins ( Figure 4C ) in the DAPK1 À/À mice. No difference of DAPK2 and DAPK3
proteins was observed between DAPK1 À/À and DAPK1 +/+ mice ( Figure 4D ). We next surveyed several synaptic proteins, including AMPA receptor subunits GluR1 and GluR2, and NMDA receptor subunits NR1, NR2A, and NR2B and PSD-95 ( Figure 4D ). We confirmed that genetic deletion of DAPK1 does not alter the overall synaptic protein compositions in the brain. We next examined synaptic transmission in the CA1 hippocampus. We analyzed excitatory post-synaptic currents (EPSCs). By plotting the mean amplitude of EPSCs in CA1 pyramidal neurons versus the stimulus intensities, we determined that the inputoutput curves were identical between genotypes ( Figure 4E ). The current-voltage (I-V) relations of AMPA receptor-and NMDA receptor-mediated EPSCs (EPSCs AMPA , Figure 4F , and EPSCs NMDA , Figure 4G ), and the induction of long-term potentiation (LTP, Figure 4H ), also were not affected in the DAPK1 À/À mice.
DAPK1 Activation Enhances Extrasynaptic NMDA Receptor Channel Activity
Having demonstrated that genetic deletion of DAPK1 did not alter NMDA receptor physiology, we next examined the functional impacts of DAPK1 deletion in NMDA receptor toxicity. First, we treated the cortical neurons from DAPK1 À/À and DAPK1 +/+ mice with oxygen/glucose deprivation (OGD). Catalytic activity of DAPK1 was measured using immune-complex kinase assay with myosin light chain (MLC) as an endogenous substrate. We found that enzymatic activity of DAPK1 began to increase 5 min after OGD, and reached a peak 30 min later (Figure 5A) . Activation of DAPK1 was maintained for over 30 min after OGD was washed out ( Figures 5A and 5B). Activation of DAPK1 was not affected by applying AMPA receptor antagonist (10 mM CNQX), but was completely eliminated either by applying NMDA receptor antagonist (50 mM D-AP5) or by removing extracellular Ca 2+ (Ca 2+ -free, Figure 5C ). Catalytic activity of DAPK1 is controlled by its autophosphorylation at serine-308 (pS 308 ); dephosphorylation of pS 308 allows DAPK1 to bind with CaM, thereby activating DAPK1 (Shohat et al., 2001) . Consistent with this previous report, we found that DAPK1 became dephosphorylated at pS 308 in cortical neurons following OGD exposure. Significantly, we showed that dephosphorylation of DAPK1 at pS 308 was catalyzed by calcineurin (CaN, see also Figure S2 ).
Next, we investigated the functional impacts of an activated DAPK1 on NMDA receptor channels in vivo. We challenged the cortical neurons with OGD or with 50 mM NMDA/10 mM glycine for 30 min to activate an endogenous DAPK1. Western blots of the precipitates showed that the levels of pS 1303 , but not the NR2B protein, were elevated in DAPK1 +/+ cortical neurons (Figure 5D ). An increase of pS 1303 in response to OGD ( Figure 5D ) or to NMDA challenging (Figures 5E and 5F) was not observed in DAPK1 À/À neurons ( Figure 5E ). Thus, an activated DAPK1 is a response to phosphorylation of NR2B subunit at Ser-1303.
To determine whether an increase of the pS 1303 level by an activated DAPK1 enhances synaptic NMDA receptor channel activity, we performed fluorescence ratio-metric Ca 2+ image combined with whole-cell patch clamp recordings. We found that Ca 2+ influx through synaptic NMDA receptor channels
were not affected by an activated DAPK1; the peak amplitudes of Ca 2+ transients were identical between groups ( Figure 5G ).
Since DAPK1 enhances the channel conductance of the recombinant NR1/NR2B receptors, which are known to be expressed predominantly in the extrasynaptic sites (Tovar and Westbrook, 1999; Brickley et al., 2003) , we reasoned that an activated DAPK1 may functionally interact with extrasynaptic NMDA receptors. To test this possibility, we recorded the extrasynaptic NMDA receptor-mediated currents (eNMDAc) and Ca 2+ transients by blocking synaptic NMDA receptor channels using MK-801 trapping protocol (for details see Experimental Procedure). We treated the single cortical neurons with OGD or 50 mM NMDA for 30 min to activate endogenous DAPK1. After a 30 min recovery period, the whole-cell currents and Ca 2+ transients were recorded ( Figure 5H ). A greater amplitude of eNMDAc and Ca 2+ transients was observed in DAPK1 +/+ neurons, compared to controls. Thus, an activated DAPK1 increases Ca 2+ influx through extrasynaptic NMDA receptor channels.
DAPK1 Deletion Protects against Cerebral Ischemic Neuronal Death
We next examined whether ischemic insult is mediated by DAPK1 induction of injurious Ca 2+ influx through extrasynaptic NMDA receptor channels. We challenged cortical cultures with OGD or 50 mM NMDA/10 mM glycine for 60 min. 24 hr after washout cell death was examined. Propidium iodide (PI) staining showed that genetic deletion of the DAPK1 gene sufficiently protected against the insults induced by either OGD or NMDA challenging ( Figures 6A and 6B ). Next, we subjected the DAPK1 À/À and DAPK1 +/+ mice with transient global ischemia by occlusion of the common carotid artery for 20 min. Six days after reperfusion, brain sections were stained with Fluoro-Jade (FJ), a marker for degenerating neurons. An unbiased stereological analysis was used to count the FJ-labeled (FJ + ) neurons in the CA1 area of the hippocampus, the layer 3 of the cortex, and the striatum. These three groups of neurons were examined because they are known to be vulnerable to transient global ischemic insult (Simon et al., 1984; Pellegrini-Giampietro et al., 1997; Wang et al., 2003a; Liu et al., 2004; Peng et al., 2006 and 92 ± 7 FJ + cell/0.2 mm 3 in the CA1 region, n = 6 mice, p < 0.01, Figure 6E ). We also operated on mice to induce focal cerebral ischemia with middle cerebral artery occlusion (MCAO) for 60 min or 120 min. After 24 hr reperfusion, the brain infarction was analyzed using TTC staining. We found that the DAPK À/À mice had a dramatic reduction of the brain infarction (14.2 ± 2.1 mm 3 at 60 min MCAO; 29.6 ± 3.3 mm 3 at 120 min MCAO, n = 11 mice/group), compared to DAPK1 +/+ mice (34.3 ± 4.6 mm 3 at 60 min MCAO; 52.9 ± 6.2 mm 3 at 120 min MCAO; n = 11 mice/group, p < 0.001, Figures 6F and 6G ). This reduction of the brain infarction was associated with improvement of the neurological scores in DAPK1 À/À mice (p < 0.01, n = 11 mice per group, Figure 6G ). Thus, DAPK1 can be considered as a primary mediator in brain damage of stroke.
Treatment of Stroke by Uncoupling DAPK1 from NMDA Receptor NR2B Subunit DAPK1 physically and functionally interacts with the NMDA receptor NR2B subunit, and this interaction might act as an essential intracellular event in stroke damage. To investigate this, we examined whether blocking DAPK1-NR2B interaction achieves the therapeutic effects in mouse models with stroke.
To do so, we generated cell membrane permeable NR2B CT peptide by fusing the NR2B CT to the cell-membrane transduction domain of the HIV-1 Tat protein (Tat-NR2B CT , for details see Experimental Procedures). Western blots of the precipitates revealed that application of Tat-NR2B CT sufficiently uncoupled an activated DAPK1 from the NMDA receptor NR2B subunit complex ( Figure 7A ). Although Tat-NR2B CT did not affect the catalytic activity of DAPK1 ( Figure 7A ), it completely blocked; [1]) an association between an activated DAPK1 and the NMDA receptor NR2B subunit; [2]) NR2B phosphorylation at Ser-1303 ( Figure 7B , see also Figure S3 ); and [3]) Ca 2+ influx through NMDA receptor channels at extrasynaptic sites ( Figure 7C ).
We next operated on mice with MCAO for 60 min, and analyzed enzymatic activity of DAPK1. Our data revealed that DAPK1 in the forebrain of mice became activated 60 min, and reached a peak 120 min after reperfusion. Activation of DAPK1 was closely associated with phosphorylation of NR2B subunit at Ser-1303 (see also Figure S3 ). Blots of the anti-NR1 precipitates in the forebrain extracts showed Tat-NR2B CT at a dose of 10 mg/kg that did not alter the catalytic activity of DAPK1, but that sufficiently uncoupled an activated DAPK1 from NMDA receptor NR2B complex (see also Figure S3 ). By measuring the cerebral infarction 24 hr after MCAO operation using TTC staining, we found that the total infarction volume in the Tat-NR2B CT -treated mice was reduced to 15.2 ± 1.2 mm 3 , compared to 37.9 ± 4.3 mm 3 in control, in which mice were injected with Tat-sNR2B CT (mean ± SEM, n = 11 mice per group, ANOVA, F = 12.98, p < 0.001, Figure 7D ). Furthermore, a significant reduction of the cerebral infarction was also observed even when Tat-NR2B CT (10 mg/kg, i.v.) was administered 60 min after MCAO operation (19.3 ± 1.9 mm 3 in the Tat-NR2B CT post-treatment, and 36.1 ± 3.7 mm 3 in Tat-sNR2B CT -posttreatment, n = 8 mice/group, Figure 7D ). A reduction of brain infarction was closely associated with improved neurological behaviors ( Figure 7D ). Together, our data demonstrate that DAPK1 physically and functionally interacts with the NMDA receptor NR2B subunit and that this interaction mediates stroke damage.
DISCUSSION
NMDA receptor NR2B subunits have recently become the major focus of studies in the treatment of stroke because of their unique features (Hardingham et al., 2002; Simpkins et al., 2003; Liu et al., 2007) . First, in the adult CNS neurons NMDA receptor NR2B subunits are localized predominantly at extrasynaptic sites (Tovar and Westbrook, 1999; Brickley et al., 2003) . This feature enables the receptor to detect extrasynaptic glutamate spillover in the brain during ischemic insults (Drejer et al., 1985; Rossi et al., 2000) . Second, extrasynaptic NMDA receptors are reported to link the specific signals that induce neuronal death in ischemia (Finkbeiner, 2000; Hardingham et al., 2002 , Takasu et al., 2002 Liu et al., 2007) . However, it is now believed that NMDA receptor NR2B subunits may be also combined with NR1/NR2A subunits to form NR1/NR2A/NR2B complex receptors at synapses (Thomas et al., 2006) . Thus, using NMDA receptor NR2B subunit antagonists for selectively inhibiting extra-synaptic NMDA receptors still could be problematic. Alternatively, recent studies have focused on NMDA receptor NR2B subunit downstream cell death signaling via interaction with PSD-95 (Aarts et al., 2002) . Disturbing NR2B-PSD-95 interaction by expression of a peptide fragment of the NR2B C-terminal tail (KLSSIESDV) uncouples neuronal nitric synthase (nNOS) activation, protecting cerebral ischemic infarction in adult rats (Aarts et al., 2002) . This finding suggests that blocking NR2B-PSD-95 interaction would be able to eliminate NMDA receptor NR2B subunit toxicity. However, this strategy has been challenged by its parallel inhibition of synaptic plasticity (El-Husseini et al., 2002) . Also, some other studies indicated that inhibition of PSD-95 increased brain damage in stroke (Gardoni et al., 2002) .
Multiple intracellular signals are able to regulate NMDA receptor channel activity (Ghosh, 2002) and induce NMDA receptor-dependent cell death (Simon et al., 1984; Wang et al., 1999) . Some including calcineurin (CaN) (Wang et al., 1999) , Ca 2+ /CaM-activated protein kinase II (CaMK-II) (Mabuchi et al., 2001) , protein kinase C (Sun et al., 2008) , cycline-dependetn kinase 5 (Cdk5) (Wang et al., 2003a) , tyrosine kinases (Khanna et al., 2007) , and nNOS (Eliasson et al., 1999) , however, also control the physiological processes of gene expression, as well as synaptic plasticity (Ghosh, 2002; Salter and Kalia, 2004) , and thus are not promising targets for stroke therapy. DAPK1 belongs to a Ca 2+ /CaM-dependent protein kinase family, and comprises a kinase domain, a CaM-binding motif, eight ankyrin repeats, and a death domain (for reviews, see Bialik and Kimchi, 2006; Van Eldik, 2002; Velentza et al., 2001 ). The kinase domain resides at the amino terminus and precedes the CaM-binding motif, which consists of a CaM binding site and an autoinhibitory region. CaM binding to the CaM binding site induces a conformation change. Ths conformation change is known to relieve the steric block of the active site by the autoinhibitory region (Van Eldik, 2002) , and possibly leads to an In panels A-G, data are mean ± SEM, *p < 0.01. activated DAPK1 binding with the NMDA receptor NR2B subunit. Consistent with this idea, our data revealed that activation of DAPK1 following ischemic insult phosphorylates the NMDA receptor NR2B subunit at Ser-1303. Interestingly, the NR2B at Ser-1303 is the same residue as that catalyzed by CaMK-II (Omkumar et al., 1996) . Thus, DAPK1 may have In panels A-H, data in bar graphs are mean ± SEM. See also Figure S2 .
a functional analogous to that of CaMK-II. CaMK-II is one of the most abundant Ca 2+ /CaM-dependent enzymes in the central neurons and participates in synaptic plasticity (Lisman et al., 2002) as well as in the cellular events responsible for ischemic neuronal death (Waxham et al., 1996) . However, CaMK-II was found to become inactivated in the brain in response to ischemic insults (Hanson et al., 1994; Waxham et al., 1996; Petersen et al., 2003) . Inhibition of CaMK-II enhances the vulnerability of brain cells to stroke damage (Waxham et al., 1996) . In this context, CaMK-II can be viewed as a neuronal survival mediator. Thus, it is unlikely that CaMK-II plays a role in the DAPK1-NR2B interaction for ischemic neuronal death.
In the present study, we used Tat-NR2B CT to disrupt the interaction between an activated DAPK1 and NMDA receptor NR2B. Tat-NR2B CT , but not its scrambled control, protected cortical neurons from NMDA receptor-mediated insults without affecting catalytic activity of DAPK1 or the NMDA receptor physiology. Thus, systematic administration of Tat-NR2B CT could serve as an advantage over NMDA receptor antagonists in stroke therapy. Indeed, our data demonstrated that Tat-NR2B CT , even when it was administered one hour after stroke onset, dramatically reduced brain infarction and improved neurological functions in mice. Thus, targeting the interaction between an activated DAPK1 and NMDA receptor NR2B could be considered a promising strategy for the treatment of stroke. It must be noted, however, that even though we found that Tat-NR2B CT disrupted (C) DAPK1 +/+ cortical neurons were treated with 50 mM Tat-sNR2B CT (purple traces) or Tat-NR2B CT (green traces) for 30 min and were then exposed to control, OGD or 50 mM NMDA/10 mM glycine for 30 min. 30 min after washout and Ca 2+ transients (top traces) whole-cell currents (bottom traces) were recorded. Data from Tat-NR2B CT (purple bars) and Tat-sNR2B CT (green bars) in bar graphs are mean ± SEM (n = 16 recordings per group, *p < 0.01).
(D) The adult male DAPK1 +/+ mice were received a single injection (10 mg/kg, i.v.) of Tat-NR2B CT (1) or Tat-sNR2B CT (2) 60 min before or 60 min after MCAO (After).
The infarction volume and neurological scores (N.S.) were summarized in the bar graphs (G). Data are mean ± SEM (*p < 0.001). See also Figure S3 .
DAPK1-NR2B interaction without interfering with the association of NR2B with PSD-95 or CaMK-II, we could not exclude the possibility that inhibition of other binding proteins, rather than DAPK1 interaction with NMDA receptor NR2B by Tat-NR2B CT , could be responsible for its neuronal protective effects. A main question arising from this study is how DAPK1 becomes activated in response to cerebral ischemic insults. Catalytic activity of DAPK1 is thought to be controlled by its autophosphorylation at serine-308 (pS 308 ); dephosphorylation of pS 308 allows DAPK1 to bind with CaM, thereby activating DAPK1 (Shohat et al., 2001) . In the present study, we showed that DAPK1 becomes dephosphorylated at pS 308 in cortical neurons following ischemic insults ( Figure S2 ). We also demonstrated that dephosphorylation of pS 308 in response to ischemic insults can be eliminated by genetic mutation of calcineurin (CaN, see also Figure S2 ). Thus, CaN can be considered as an upstream activator of DAPK1. It has been known that enzymatic activity of CaN depends on Ca 2+ influx through NMDA receptor channels (Marshall et al., 2003) . Consistent with this previous report, our data revealed that challenging cortical neurons with NMDA induced dephosphorylation of pS 308 ( Figures 5C-5E ). Conversely, application of NMDA receptor antagonist or removal of extracellular Ca 2+ inhibits DAPK1 dephosphorylation at pS 308 and inactivates DAPK1 ( Figure 5C , see also Figure S2 ). Thus, the most parsimonious explanation for our findings is that under physiological conditions, an initial Ca 2+ influx through NMDA receptor channels produces partial inhibition of NMDA receptors via Ca
2+
-dependent inactivation, thereby preventing the intracellular Ca 2+ overloading (Krupp et al., 1999) . Under pathological conditions such as ischemic insults, however, Ca 2+ influx through NMDA receptor channels activates CaN and in turn dephosphorylates DAPK1 at pS 308 , leading to activation of DAPK1. An activated DAPK1 is recruited into the NMDA receptor NR2B subunit at extrasynaptic sites and phosphorylates NR2B subunit at Ser-1303 and subsequently induces injurious Ca 2+ influx through NMDA receptor channels, resulting in an irreversible neuronal death. Thus, DAPK1 can be considered as a signaling amplifier of NMDA receptors at extrasynaptic sites for mediating brain damage in stroke.
EXPERIMENTAL PROCEDURES Generation of DAPK1 Null Mutant Mice
The null mutant mice with complete deletion of DAPK1 gene were generated using a gene-trapping technique. A mouse (strain C57/Bl6) was cloned from an embryonic stem cell line (IST12766D5; Texas Institute for Genomic Medicine, TIGM), carrying DAPK1 allele disrupted by the insertion of a gene trap vector with a lacZ (b-galactosidase)-neomycin resistance fusion cassette (b-gal, Omnibank Vector 76) in the first intron. The insertion site, as denoted with an asterisk*, was confirmed by genomic sequence, which is available upon requested. The cloned ES cell was used to generate DAPK1 mutant mice with a C57/Bl6 background, which were verified by PCR amplification of the mutant gene in tail DNA from progeny. The homozygous (DAPK1 À/À ) mice were derived by mating heterozygous DAPK1 +/À mice. The PCR primers for wild DAPK1 were as follows: sense 5 0 TTGCACAACAGCTACACAGC-3 00 antisense 5 0 ATAGTCCCACTACTCAGGTC-3 0 .
Focal Cerebral Ischemia and Transient Global Ischemia DAPK1 mutant mice were fasted overnight, and anesthetized with 4% halothane and maintained with mechanical ventilation (3.5 ml / cycle, 28 cycle / min, 0.5% halothane in a mixture of 30% O 2 and 70% N 2 O). The blood gas conditions were kept at constant levels throughout the surgery (P O2 , 120 ± 10 mm Hg; P CO2 , 35 ± 3 mm Hg), and the rectal and temporal muscle temperatures were also maintained at 37.5 ± 0.2 C and 37.0 ± 0.1 C, respectively. Body temperature was maintained at 37 ± 0.5 C with heating pads until the animals had recovered from surgery. Focal cerebral ischemia was induced by intraluminal middle cerebral artery occlusion (MCAO), as described previously. Local blood flow was monitored using BLF21C Laser Doppler Flow-meter with LL-M1043 fiber flow-probe (Transonic System Inc, New York), as described before (Wang et al., 2003a; Liu et al., 2004; Peng et al., 2006 , see also Extended Experimental Procedures).
Administration of Tat-NR2B CT Mice were intravenously (i.v.) administered with 10 mg/kg Tat-NR2B CT (Tat-KKNRNKLRRQHSY) or Tat-sNR2B CT (Tat-NRRRNSKLQHKKY) 60 min before or after MCAO operation. To test whether the Tat-peptide could be delivered into the brain, the Tat-NR2N CT -fluorescein isothiocyanate (FITC, 10 mg/kg, i.v.) was injected. 30 min after the injection, the brain sections (30 mm) were imaged under the Axio Observer 200 Apotome microscope (data not shown).
For the electrophysiological recordings, 50 mM NR2B CT or sNR2B CT was applied directly into the recording cells via patch electrode. A dose of 10 mg/kg tat peptide or 50 mM NR2B CT peptide was chosen because we found they did not alter DAPK1 activity but uncoupled an activated DAPK1 from NMDA receptor complex. The peptides with 99% purity were synthesized by AnaSpec (San Jose, CA) and Peptide 2.0, Inc (Chantilly, VA), respectively. The peptides were numbered and the experimenters were unaware of which onewas applied in all experiments.
Whole-Cell Patch Clamp Recordings
Hippocampal slices (300 mm) were prepared from mice as previously described (Wang et al., 2003a; 2003b; Liu et al., 2004; Peng et al., 2006 , see also Extended Experimental Procedures). Slices in the recording chamber were continuously superfused with artificial cerebrospinal fluid (ACSF, 2 ml/min) saturated with 95% O 2 /5% CO 2 at 30 ± 1 C. The composition of ACSF (in mM) was 124 NaCl, 3 KCl, 1.25 NaH 2 PO 4 , 1.2 MgCl 2 , 2 CaCl 2 , 26 NaHCO 3 , and 10 dextrose.
Co-IP, Affinity Binding Assay, and Western Blots Cerebral cortex was homogenized in ice-cold lysis buffer containing (mM) 50 Tris-HCl, 150 NaCl, 1% NP-40, 2 EDTA, 1 Na-orthovanadate, (pH 7.4), and proteinase inhibitor mixture (Sigma, 5 ml/100 mg tissue). After clearing debris by centrifuging at 14,000 3 g at 4 C, protein concentration in the extracts was determined by Bradford assay (Bio-Rad, Hercules, CA). The extracts ($500 mg protein) were incubated with nonspecific IgG (2 mg) or polyclonal rabbit anti-NR2B (2 mg; Millipore) or anti-DAPK1 (2 mg, Sigma) overnight at 4 C, followed by the addition of 40 ml of Protein G-Sepharose (Sigma) for 3 hr at 4 C. The precipitates were washed four times with lysis buffer and denatured with SDS sample buffer and separated by 12% SDS-PAGE. Proteins were transferred onto nitrocellulose membranes using a Bio-Rad miniprotein-III wet transfer unit overnight at 4 C. Transfer membranes were then incubated with blocking solution [5% nonfat dried milk dissolved in TBST buffer containing (mM); 10 Tris-HCl, 150 NaCl, and 0.1% Tween-20 for 1 hr at room temperature, washed three times, and incubated with anti-goat primary antibody against NR1 (1:1000, Santa Cruz), anti-rabbit antibody against NR2A (anti-NR2A, 1:1000; Millipore), NR2B (anti-NR2B, 1:1000; Millipore), PSD-95 (anti-PSD-95, 1:1000; Santa Cruz), or anti-DAPK1 (1: 1000, Sigma) for 1 hr at room temperature. Membranes were washed three times with TBST buffer and incubated with the appropriate secondary antibodies (1:1000 dilution) for 1 hr followed by washing four times. Signal detection was performed with an enhanced chemiluminescence kit (Amersham Biosciences, Arlington, IL). The lanes marked ''input'' were loaded with 10% of the starting material used for immunoprecipitation.
To determine direct binding of DAPK1 with NMDA receptor NR2B C-terminal domain, the GST-NR2B deletion mutants (GST-NR2B , GST-NR2B 839-1261 , GST-NR2B 1261 -1292 , GST-NR2B 1292 -1304 , and GST-NR2B ) were generated and purified. Purified GST fusion proteins were separated on SDS-PAGE and transferred onto a nitrocellulose membrane, which was washed with distilled water and blocked with TBST for 1 hr at room temperature. The membrane was then incubated with affinity binding buffer containing 50 mM Tris-HCl, (pH 7.5), 200 mM NaCl, 12 mM b-mercaptoethanol, 1.0% polyethylene glycol, 10 mg/ml protease inhibitors and 500 mg/ml purified flag-tagged DAPK1 (Invitrogen) for 1 hr at room temperature and washed four times for 5 min with affinity binding buffer. Bound DAPK1 was detected with anti-Flag (1: 2000, Invitrogen).
Protein Identification
Protein bands were excised manually from the Coomassie blue-stained gels and then digested automatically using a Proteineer DP protein digestion station (Bruker-Daltonics, Bremen, Germany). Tryptic products were analyzed using Nano-Liquid Chromatography-Tandem Mass Spectrometry (NLC/MS). Each spectrum was internally calibrated with mass signals of trypsin autolysis ions to reach a typical mass measurement accuracy of ± 10 ppm. Raw data were searched in the SWISS-PROT database.
Cell Cultures and Oxygen-Glucose Deprivation Hippocampi were isolated from the E20 DAPK1 mice. Cells were dissociated and purified using papain dissociation kit (Worthington Biochemical Corporation) platted with the densities of 100-150 cells/mm for Ca 2+ image or 800-1000 cells/mm for OGD on 19 mm coverslips coated with 30 mg/ml poly-D-lysine and 2 mg/ml laminin. Cells were placed in fresh serum-free Neurobasal Medium (21103, GIBCO) plus 2% B27 and fed every 4 days with fresh media and used after 18 days (DIV18). Oxygen/glucose deprivation (OGD) was induced by perfusion (2 ml/min) of a glucose-free bicarbonatebuffer containing (in mM) 120 NaCl, 5 KCl, 2.0 CaCl 2 , 0.8 MgCl 2 , 25 NaHCO 3 , (pH 7.4), at 32 C, saturated with 5% CO 2 /10% H 2 /85%N 2 for 0, 5, 15, or 30 min. Zero or 30 min after OGD washout, the cultures were used for enzymatic assays. In all NMDA treatment, 10 mM glycine was included. The phosphorylated myosine light chain (MLC) at Thr-18 and Ser-18 (pMLC) that was catalyzed by an activated DAPK1 in the lysates was blotted with anti-pMLC (1:1000, Millipore) or anti-pDAPK1 (1:500, Millipore) that specifically recognizes the phosphorylated DAPK1 at Ser-308. For measurement of phosphorylation of the NMDA receptor NR2B subunit at Ser-1303 (pS 1303 ), the NMDA receptor complex was immunoprecipitated using anti-NR1. The precipitates were then probed using anit-pS 1303 (1:1000, anti-phospho-NR2B at Ser1303 with antigene: RRQHpSYDTF, Millipore). The bands were quantified using ''the normalized method'' of the densitometer Quantity One following the Quantity One user instructions (Bio-Rad). The intensities of the bands marked ''0'' in each gel were normalized as 1. Each of the other bands in the same gel was then normalized to ''0'' bands.
Ca
2+ Imaging
For Ca 2+ imaging, the neuronal cultures were loaded with fura-2-AM (1 mM, Invitrogen) for 30 min followed by 5 washes for 30 min. The cultures were then subjected to OGD for 30 min (OGD, pre-OGD-treated) or 0 min (control). The 30 min OGD was chosen because it activates DAPK1 without causing morphological changes, thereby ensuring accurate measurement of Ca 2+ signals in single neurons. Immediately after OGD washout, the cultures were perfused at 4 ml/min with a glucose-containing bicarbonate buffer 135 NaCl, 5 KCl, 2.0 CaCl 2 , 25 NaHCO 3 , and 10 glucose, (pH 7.4), at 32 C, saturated with 5% CO 2 /10% H 2 /85%O 2 . Synaptic NMDA receptors were activated by applying 30 mM bicuculline (Bic)/2 mM 4-AP in the presence of 10 mM nifedipine. One min after Bic/4-AP, MK-801 (20 mM, Sigma) was applied for blocking synaptic NMDA receptor channels. Since MK-801 is an irreversible open channel blocker, activated synaptic NMDA receptor channels remained blocked after MK-801 washout. To ensure these synaptic NMDA receptor channels were not reactivated, we applied AMPA receptor antagonist CNQX (10 mM) to block neuronal spontaneous firing. The extrasynaptic NMDA receptors were activated by a 5 ms pulse of 100 mM NMDA/10 mM glycine (Sigma) in the presence of 10 mM CNQX (Tocris) and 10 mM nifendipine (Sigma). One min later 10 mM ifenprodil was applied using SmartSquirt 4-Micro-Perfu- 
